Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis

MLA

Kitae Park, et al. “Cationic Solid Lipid Nanoparticles Derived from Apolipoprotein-Free LDLs for Target Specific Systemic Treatment of Liver Fibrosis.” Biomaterials, vol. 34, Jan. 2013, pp. 542–51. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2012.09.067.

APA

Kitae Park, Dong Kyung Sung, Hwiwon Lee, Min-Young Lee, Sei Kwang Hahn, & Won Ho Kong. (2013). Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis. Biomaterials, 34, 542–551. https://doi.org/10.1016/j.biomaterials.2012.09.067

Chicago

Kitae Park, Dong Kyung Sung, Hwiwon Lee, Min-Young Lee, Sei Kwang Hahn, and Won Ho Kong. 2013. “Cationic Solid Lipid Nanoparticles Derived from Apolipoprotein-Free LDLs for Target Specific Systemic Treatment of Liver Fibrosis.” Biomaterials 34 (January): 542–51. doi:10.1016/j.biomaterials.2012.09.067.